Trademarkia Logo

Canada

C$
ARVINAS & DESIGN
SEARCHED

on 8 Oct 2024

Last Applicant/ Owned by

ARVINAS OPERATIONS INC.

5 Science ParkNew Haven, CT 06511

US

Serial Number

2195608 filed on 30th Jun 2022

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

ARVINAS & DESIGN

Trademark usage description

pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders. pharmaceutical Read More

Vienna Information


24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 14

Dotted lines or bandsLignes ou bandes pointillées

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information


Class [005]
Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, and central nervous system disorders.


Classification kind code

11

Class [042]
Pharmaceutical products development of new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.


Classification kind code

11

Mark Details


Serial Number

2195608

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 8th Oct 2024
Search Recorded
Submitted for opposition 20
on 8th Oct 2024
Examiner's First Report
Submitted for opposition 287
on 22nd Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 30th Jun 2022
Filed
Submitted for opposition 1
on 30th Jun 2022
Created
Submitted for opposition 31
on 30th Jun 2022
Formalized